403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Three Sci-tech innovation IPOs in China approved
(MENAFN)
The initial public offering (IPO) of three companies on the science and technology innovation board has been approved by the securities regulator in China.
Shanghai Taitan Scientific Co., Ltd., Frontier Biotechnologies Inc. and Shenzhen Consys Science & Technology Co., Ltd. are both going to be listed on the Shanghai Stock Exchange's sci-tech innovation board, which is also called the STAR market the China Securities Regulatory Commission said.
The companies and their underwriters are going to confirm the IPO dates and released their prospectuses after discussions with the stock exchange.
The STAR market that was made in June of the earlier year to support firms in the high-tech and strategic emerging sectors, makes listing criteria easier but it has higher requirements for information disclosure.
The initial public offering (IPO) of three companies on the science and technology innovation board has been approved by the securities regulator in China.
Shanghai Taitan Scientific Co., Ltd., Frontier Biotechnologies Inc. and Shenzhen Consys Science & Technology Co., Ltd. are both going to be listed on the Shanghai Stock Exchange's sci-tech innovation board, which is also called the STAR market the China Securities Regulatory Commission said.
The companies and their underwriters are going to confirm the IPO dates and released their prospectuses after discussions with the stock exchange.
The STAR market that was made in June of the earlier year to support firms in the high-tech and strategic emerging sectors, makes listing criteria easier but it has higher requirements for information disclosure.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment